SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Century Therapeutics Reports Q3 2026 Loss of $23.5 Million, Cash of $174.1 Million

Century Therapeutics reported a third-quarter 2026 net loss of $23.5 million, compared with a $34.4 million loss a year earlier. Research and development expenses declined to $18.1 million, while cash, cash equivalents and investments totaled $174.1 million at September 30, 2026. The company said i…

IPSC

Related stories